Renewed Interest in Measles Treatments as Vaccination Rates Decline
By
Teddy Rosenbluth
Summary
The article reports on renewed interest in developing treatments for measles as vaccination rates decline and outbreaks return. Researcher Dawid Zyla at the La Jolla Institute for Immunology faced skepticism when he began studying measles in 2020, as the virus was considered a problem of the past due to effective vaccines. However, with falling vaccination rates creating a potential new market, biotech companies are now exploring measles drug development.
Source
Key quotes
· 1 pulledThere was zero interest in it.
You might also wanna read
CDC Considers Tracking Non-Measles Cases Amid Record Outbreak
The CDC, facing the largest measles outbreak in decades, has stated that due to overwhelming caseloads and dropping vaccination rates, it wo
Canada loses measles elimination status as outbreak continues for 12 months
Canada has lost its measles elimination status after failing to control an outbreak for 12 consecutive months, with over 5,000 cases reporte
Romania accounts for over half of EU/EEA measles cases in 2025 as vaccination gaps persist
Romania remains Europe's measles hotspot, accounting for over half of all 7,655 reported measles cases across 30 EU/EEA countries in 2025. W
Utah measles outbreak reaches 679 cases, threatening US elimination status
A measles outbreak in Utah has reached 679 cases, lasting over a year and representing the longest continuous spread in the US since last ye
Diphtheria, a Once Vanquished Killer of Children, Is Resurgent

Shingles Vaccination Reduces Mild Cognitive Impairment and Dementia-Related Deaths, Study Finds
A natural experiment study found that herpes zoster (shingles) vaccination reduces the occurrence of mild cognitive impairment and deaths du
Comments
Sign in to join the conversation.
No comments yet. Be the first.
